Literature DB >> 15388876

Stop codon-mediated suppression of splicing is a novel nuclear scanning mechanism not affected by elements of protein synthesis and NMD.

Chaim Wachtel1, Binghui Li, Joseph Sperling, Ruth Sperling.   

Abstract

The pre-mRNA splicing machine must frequently discriminate between normal and many potential 5'splice sites that match the consensus sequence but remain latent. Suppression of splicing (SOS) at such latent 5'splice sites is required for the maintenance of an open reading frame, and to ensure that only RNAs that encode for functional proteins will be formed. In this study we show that SOS is a novel mechanism distinct from the known RNA surveillance mechanisms. First, SOS is distinct from nonsense-mediated mRNA decay (NMD) because it is not dependent on translation and is not affected by RNAi-mediated down-regulation of hUpf1 and hUpf2--two key components of the NMD pathway. Second, SOS is distinct from nonsense-associated alternative splicing (NAS), because a mutant of hUpf1, which was shown to abrogate NAS, does not activate latent splicing. Elucidating the mechanism of SOS is pertinent to human disease in view of the large number of human genes that harbor latent splice sites.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15388876      PMCID: PMC1370662          DOI: 10.1261/rna.7480804

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  48 in total

Review 1.  Nonsense-mediated mRNA decay in health and disease.

Authors:  P A Frischmeyer; H C Dietz
Journal:  Hum Mol Genet       Date:  1999       Impact factor: 6.150

Review 2.  RNA surveillance. Unforeseen consequences for gene expression, inherited genetic disorders and cancer.

Authors:  M R Culbertson
Journal:  Trends Genet       Date:  1999-02       Impact factor: 11.639

Review 3.  A perfect message: RNA surveillance and nonsense-mediated decay.

Authors:  M W Hentze; A E Kulozik
Journal:  Cell       Date:  1999-02-05       Impact factor: 41.582

4.  A premature termination codon interferes with the nuclear function of an exon splicing enhancer in an open reading frame-dependent manner.

Authors:  A Gersappe; D J Pintel
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

Review 5.  The association of nonsense codons with exon skipping.

Authors:  C R Valentine
Journal:  Mutat Res       Date:  1998-09       Impact factor: 2.433

Review 6.  Interrelationships of the pathways of mRNA decay and translation in eukaryotic cells.

Authors:  A Jacobson; S W Peltz
Journal:  Annu Rev Biochem       Date:  1996       Impact factor: 23.643

7.  Proofreading and aminoacylation of tRNAs before export from the nucleus.

Authors:  E Lund; J E Dahlberg
Journal:  Science       Date:  1998-12-11       Impact factor: 47.728

8.  Nonsense mutations inhibit RNA splicing in a cell-free system: recognition of mutant codon is independent of protein synthesis.

Authors:  S Aoufouchi; J Yélamos; C Milstein
Journal:  Cell       Date:  1996-05-03       Impact factor: 41.582

9.  A mutated human homologue to yeast Upf1 protein has a dominant-negative effect on the decay of nonsense-containing mRNAs in mammalian cells.

Authors:  X Sun; H A Perlick; H C Dietz; L E Maquat
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

10.  Intron function in the nonsense-mediated decay of beta-globin mRNA: indications that pre-mRNA splicing in the nucleus can influence mRNA translation in the cytoplasm.

Authors:  J Zhang; X Sun; Y Qian; L E Maquat
Journal:  RNA       Date:  1998-07       Impact factor: 4.942

View more
  14 in total

1.  A potential role for initiator-tRNA in pre-mRNA splicing regulation.

Authors:  Eyal Kamhi; Oleg Raitskin; Ruth Sperling; Joseph Sperling
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

2.  Loss of exon identity is a common mechanism of human inherited disease.

Authors:  Timothy Sterne-Weiler; Jonathan Howard; Matthew Mort; David N Cooper; Jeremy R Sanford
Journal:  Genome Res       Date:  2011-07-12       Impact factor: 9.043

3.  Heat shock activates splicing at latent alternative 5' splice sites in nematodes.

Authors:  Yuval Nevo; Joseph Sperling; Ruth Sperling
Journal:  Nucleus       Date:  2015-01-29       Impact factor: 4.197

4.  Association of ribosomal proteins with nascent transcripts in S. cerevisiae.

Authors:  Patricia A Schroder; Melissa J Moore
Journal:  RNA       Date:  2005-10       Impact factor: 4.942

5.  The editing enzyme ADAR1 and the mRNA surveillance protein hUpf1 interact in the cell nucleus.

Authors:  Lily Agranat; Oleg Raitskin; Joseph Sperling; Ruth Sperling
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-24       Impact factor: 11.205

6.  Cotranscriptional effect of a premature termination codon revealed by live-cell imaging.

Authors:  Valeria de Turris; Pamela Nicholson; Rodolfo Zamudio Orozco; Robert H Singer; Oliver Mühlemann
Journal:  RNA       Date:  2011-10-25       Impact factor: 4.942

7.  AUG sequences are required to sustain nonsense-codon-mediated suppression of splicing.

Authors:  Eyal Kamhi; Galit Yahalom; Gideon Kass; Yael Hacham; Ruth Sperling; Joseph Sperling
Journal:  Nucleic Acids Res       Date:  2006-07-19       Impact factor: 16.971

Review 8.  The Supraspliceosome - A Multi-Task Machine for Regulated Pre-mRNA Processing in the Cell Nucleus.

Authors:  Kinneret Shefer; Joseph Sperling; Ruth Sperling
Journal:  Comput Struct Biotechnol J       Date:  2014-09-28       Impact factor: 7.271

9.  Frame-disrupting mutations elicit pre-mRNA accumulation independently of frame disruption.

Authors:  J Saadi Imam; Jayanthi P Gudikote; Wai-Kin Chan; Miles F Wilkinson
Journal:  Nucleic Acids Res       Date:  2009-12-09       Impact factor: 16.971

10.  Genome-wide activation of latent donor splice sites in stress and disease.

Authors:  Yuval Nevo; Eyal Kamhi; Jasmine Jacob-Hirsch; Ninette Amariglio; Gideon Rechavi; Joseph Sperling; Ruth Sperling
Journal:  Nucleic Acids Res       Date:  2012-09-23       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.